# Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)

> **NCT05462574** · — · RECRUITING · sponsor: **Vanderbilt University Medical Center** · enrollment: 75 (estimated)

## Conditions studied

- Idiopathic Pulmonary Arterial Hypertension
- Heritable Pulmonary Arterial Hypertension
- Pulmonary Arterial Hypertension Associated With Connective Tissue Disease

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT05462574
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-17
- **Primary completion:** 2027-09-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2025-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05462574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05462574, "Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05462574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*